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An alternative for rapid administration of medication and ﬂuids in the
emergency setting using a novel device☆,☆☆Abstract
Routes of administration formedications and ﬂuids in the acute care
setting have primarily focused on oral, intravenous, or intraosseous
routes, but, in many patients, none of these routes is optimal. A
novel device (Macy Catheter; Hospi Corp) that offers an easy route for
administration of medications or ﬂuids via rectal mucosal absorption
(proctoclysis) has recently become available in the palliative care
market; we describe here the ﬁrst known uses of this device in the
emergency setting. Three patients presenting to the hospital with
conditions limiting more typical routes of medication or ﬂuid adminis-
tration were treated with this new device; patients were administered
water for hydration, lorazepam for treatment of alcohol withdrawal,
ondansetron for nausea, acetaminophen for fever, aspirin for antiplate-
let effect, and methimazole for hyperthyroidism. Placement of the de-
vice was straightforward, absorption of administered medications
(judged by immediacy of effects, where observable) was rapid, and
use of the device was well tolerated by patients, suggesting that this
device may be an appealing alternative route to medication and
ﬂuid administration for a variety of indications in acute and critical
care settings.
Routes of administration formedications and ﬂuids in the acute care
setting, such as emergency departments (EDs) and intensive care units
(ICUs) have primarily focused on oral, intravenous (IV), or intraosseous
routes, but, in many patients, none of these routes is optimal. Patients
who are volume depleted, with difﬁcult vascular access, and poor oral
tolerance are often not sick enough to require central line placement
or sedated enough to tolerate intraosseous placement.
A novel device (Macy Catheter; Hospi Corp) that offers an easy route
for administration ofmedications or ﬂuids via rectalmucosal absorption
(proctoclysis) has recently become available in the palliative care mar-
ket. The catheter is a thin silicone tube 14F in diameter with a 15-mL
balloon at the tip (sized to allow secure retention yet also provide for
ready elimination in the event of need for defecation), multiple exit
ports for ﬂuid and medication passage, and an internal 1-way check
valve to prevent backﬂow of ﬂuids. Hypothesizing the potential beneﬁts
of this approach in awider patient population,we describe here theﬁrst
known uses of this device in the acute care (ED and ICU) setting.☆ Funding: None.
☆ Conﬂicts of interest: None.
0735-6757/© 2015 The Authors. Published by Elsevier Inc. This is an open access article underAn 80-year-old man with multiple medical comorbidities (obesity,
chronic leg wound, skin grafts, hypertension, coronary artery disease,
and chronic obstructive pulmonary disease) presented to the ED via
ambulance with fever, decreased mental status, and cough. Attempts
at IV access by ambulance personnel were unsuccessful. Initial vital
signs were blood pressure (BP), 124/68 mm Hg; heart rate (HR),
98 beats per minute; temperature (T), 38.4°C; oxygen saturation of
92% on 2-L nasal cannula; and Glasgow Coma Scale of 14 (due to confu-
sion). Because the patient's mental status was felt to preclude oral
administration, but his BP and clinical condition did not warrant central
IV access,we began treatment via placement of theMacy Catheter,where-
as laboratorieswere drawn, and peripheral IV accesswas attempted in the
ED. After the Macy Catheter was placed in the rectum, the balloon was
inﬂated with water, and we administered a total of 50 mL of ﬂuids and
medications, includingwater, aspirin tablets dissolved inwater, and aceta-
minophen (oral formulation), whereas peripheral IV access was
established. Approximately 90 minutes later, the patient was afebrile
(36.5°C), alert, and oriented, with laboratories showing an elevated
white blood cell count and chest x-ray demonstrating pneumonia.
After demonstrating the ability to tolerate oral liquids, the Macy
Catheter was removed.
A 41-year-old woman presented via ambulance in alcohol
withdrawal with vital signs of BP, 110/78 mm Hg; HR, 120 beats per
minute; T, 36.9°C; and oxygen saturation of 98% on room air. Her
Clinical Institute Withdrawal Assessment of Alcohol score was 9.
Attempts at obtaining IV access for administration of ﬂuids and
benzodiazepines were unsuccessful, and the patient was deemed too
disoriented and agitated to safely tolerate oral administration. The Macy
Catheter was consequently placed without difﬁculty, and 2 mg of loraze-
pam were administered, resulting in immediate improvement of the
patient's agitation, orientation, and tachycardia. The patient was then
given 4 mg of ondansetron via the Macy Catheter, along with multiple ali-
quots of tap water at a rate of 10mL every 2 to 10minutes over the subse-
quent hour, resolving her tachycardia and eliminating her nausea. Her
Clinical InstituteWithdrawalAssessmentofAlcohol scoredecreased to zero.
A 25-year-old woman presented via ambulance with acute confu-
sion, agitation, and tachycardia resulting from substance abuse (cocaine
and heroin) with an underlying untreated hyperthyroidism for which
the patient was previously taking methimazole. Her vital signs were
BP, 118/73 mm Hg; HR, 117 beats per minute; T, 37.4°C; and oxygen
saturation of 97% on room air. Intravenous access was established
with some difﬁculty; however, the patient remained too confused and
agitated to safely tolerate methimazole, which is only available in tablet
form. To administer hermethimazole, theMacy Catheterwas easily placed;
the methimazole tablets were administered after being crushed andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the ICU for subsequent administrations every 6 hours, until the
patient improved sufﬁciently to begin tolerating oral intake the day
after admission.
The absorption of ﬂuids and a wide variety of medications by the
rectal mucosa is well described [1-5]. In fact, the administration of
ﬂuids for hydration is speciﬁcally referred to as proctoclysis or
rectoclysis and has a long history of use, dating back to at least the
early 1900s [6-9]. A recent report highlights the potential of this ap-
proach in emergent and remote settings because no sterility or
complex training is required [10]. However, practical use of this
route has been limited due to the lack of a simple, effective means
of administration with the ability to ensure secure retention of the
administered ﬂuids or medications.
The Macy Catheter became available in 2014, intended for pal-
liative care and hospice patients. Because of its simplicity and po-
tential attractiveness for use with our acute care patient
population, our hospital recently began trialing the Macy Catheter
for emergency and intensive care patients and has identiﬁed a
number of beneﬁts to this approach. Placement is easy and fast,
with no need for sterility or advanced training, as the device is
placed analogously to a standard Foley catheter but in the rectum
rather than bladder. Absorption through rectal mucosa is rapid,
with blood levels of many drugs (aqueous and alcoholic solutions
in particular) becoming therapeutic very rapidly (potentially due
to avoidance of the ﬁrst-pass effect) [11]. Our experience has
found that noticeable effects of lorazepam occurred less than
1 minute after rectal administration via the Macy Catheter and
that the antipyretic effects of acetaminophen and antiemetic
effects of ondansetron also appeared soon after administration.
The avoidance of the need for repeated attempts at difﬁcult vascu-
lar access or placement of central venous access is appreciated by
nurses, physicians, and patients alike.
Limitations of this report include the inherent retrospective
nature of a case series. We did not perform a formal measurement
of the total volumes of ﬂuids administered or obtain a robust quan-
tiﬁcation of the timing between administration and observation of
effects. We did not perform any pharmacokinetic laboratory mea-
sures to determine efﬁcacy of administered medications and relied
solely on clinical response. As recommended by the manufacturer,
we used plain tap water for all of our ﬂushes and to dissolve the
oral formulations of aspirin and methimazole. Absorption from
suppositories is generally slower than aqueous solutions and is
dependent on the nature of the suppository base [11], but subtle
inﬂuences on absorption rates from other unmeasured factors may
inﬂuence our ﬁndings.
In summary, a novel rectal administration device appears to offer an
appealing alternative route to medication and ﬂuid administration for a
variety of indications in acute and critical care settings.Neal Lyons, PharmD
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